Agnieszka K. Witkiewicz

机构：Roswell Park Comprehensive Cancer Center · ORCID：0000-0003-4538-1145

发表论文 461 篇 · 总被引 20084 次 · h-index 72

代表论文

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial (2026 · Nature Communications · 被引 6)
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond (2026 · Nature Reviews Drug Discovery · 被引 2)
Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort (2026 · Modern Pathology · 被引 1)
HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma (2026 · Communications Biology)
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor–Resistant HR+/HER2− Breast Cancer (2026 · Cancer Research)
Supplementary Table S3 from Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models (2026)